Vaxcyte appoints Elvia Cowan as principal accounting officer effective Jan 1, 2023

Vaxcyte, Inc.

Elvia Cowan, 50, currently SVP Finance since July 2022, appointed principal accounting officer.
Previously VP Controller at 23andMe (Oct 2018 - Mar 2022) and CFO at Ruby Ribbon.
Andrew Guggenhime remains President and CFO, stepping down as principal accounting officer.
Cowan is a CPA in California and holds a B.A. in Business Administration from Mount Saint Mary's University.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Elvia Cowan

Principal Accounting Officer

PCVX · Vaxcyte, Inc.

Effective: 2023-01-01
Filed: December 12, 2022, 6:59 PM ET

On December 6, 2022, the Board of Directors of Vaxcyte, Inc. (the “Company”) appointed Elvia Cowan, its Senior Vice President, Finance, as the Company’s principal accounting officer, effective January 1, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Elvia Cowan was appointed as Principal Accounting Officer at Vaxcyte, Inc..

Action: appointed
Role: Principal Accounting Officer

Exact text from the filing

On December 6, 2022, the Board of Directors of Vaxcyte, Inc. (the “Company”) appointed Elvia Cowan, its Senior Vice President, Finance, as the Company’s principal accounting officer, effective January 1, 2023.

View on SEC.gov

Vaxcyte, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-302736

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.